Clinical trial
Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes…
NCT00315718 · Harras Pharma Curarina GmbH, Industry · Completed
Key facts
| NCT number | NCT00315718 |
|---|---|
| Title | Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes Mellitus (Type 2) |
| Official title | Controlled Clinical Trial on Long Term Effects of Hintonia Latiflora Extract in Mild to Moderate Type 2 Diabetes |
| Lead sponsor | Harras Pharma Curarina GmbH, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Extract from Hintonia latiflora bark |
| Enrollment | 10 |
| Start date | Jun 1, 2002 |
| Completion | Jun 1, 2005 |
| First posted | Apr 19, 2006 |
| Last update posted | Apr 19, 2006 |
| Countries | Slovakia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: